Buying its own future output: the company is spending now to own more of the value it already helps create
The model's full reasoning — Q2 2022 call → NOThe question asks whether management describes the company as currently moving itself further up or down its own value chain — taking ownership or direct control of a step in the chain that someone else used to perform, own, or capture the margin on — and whether this move is already being executed and is already changing what the company earns or can do. Let me review the transcript for any such description. Key topics discussed: 1. Trading volumes and financial results 2. Investment in S&P Dow Jones Indices JV ($410 million) — this funded the acquisition of IHS Markit Indices business, keeping their 27% ownership stake. This is an investment in an existing joint venture, not taking over a step in the chain. 3. SOFR/LIBOR transition 4. BrokerTec/EBS migration to Globex 5. Google partnership and cloud migration 6. Retail and event contracts 7. Market data Let me look for any vertical integration or value chain moves. The S&P Dow Jones Indices JV investment — this is buying into an existing JV to fund an acquisition of IHS Markit Indices. This is an investment in a joint venture they already own 27% of. It's not taking over a step in the chain that someone else used to perform. It's expanding the JV's product scope. This doesn't seem to fit. The OSTTRA joint venture with S&P Global — formed in Q4 of last year, combining their post-trade optimization businesses with MarkitSERV. This is a joint venture, not taking over a step from someone else. It's combining businesses. The cloud migration with Google — this is moving to the cloud, not taking over a step in the chain. The event contracts — launching new products, not vertical integration. The BrokerTec/EBS migration to Globex — this is bringing their own acquired platforms onto their own technology, but these were already owned by CME (from the NEX acquisition). This is integration of acquired businesses, not taking over a step from an external party. None of these seem to describe the company taking ownership or direct control of a step in the chain that someone else used to perform. The question is quite specific: "taking ownership or direct control of a step in the chain that someone else used to perform, own, or capture the margin on." Looking at the transcript, I don't see management describing such a move.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
FLEX · Q1 2018 → YESThe question is about whether Flex Ltd is currently moving itself further up or down its own value chain by taking ownership or control of a step that someone else used to perform. YES The transcript shows Flex is actively internalizing a previously external step in the shoe manufacturing value chain by taking ownership of automation, process redesign, and end-to-end production for Nike. Management describes this as an ongoing, real-time execution: “we’re vertically integrating technologies,” “rethinking all of the whole supply process we’re applying automation technologies,” “we’ve manufactured over 1 million pairs,” and “we took over the facility in September” for Bose, with the Nike factory transition “complete by October.” They explain the value capture: the company now keeps margin it previously paid away, controls quality, cost, supply, and timing previously constrained by a counterparty, and serves customers it could not reach through the old chain. While acknowledging the ramp is early (losses persist through Q2, breakeven expected by year-end), the move is already changing what Flex earns and can do, not merely planned or contemplated. This meets all three required elements.
XOM · Q2 2018 → YESThe question is about whether ExxonMobil is currently moving itself further up or down its own value chain by taking ownership or control of a step that someone else used to perform. YES The transcript shows ExxonMobil actively internalizing logistics and supply-chain steps that previously required external partners or intermediaries. Neil Chapman explicitly states they “will get engaged in the connectivity between the Permian and our Gulf Coast refining and chemical assets,” with equity participation in logistics, the Wink terminal acquisition (closed late 2017), 11 active completion crews, and a signed letter of intent for a 1 million bpd long-haul crude pipeline. These moves are already producing results: Gulf Coast refineries are “already processing our production levels and more, capturing the benefits of disadvantaged feed cost.
KMDA · Q2 2023 → YESThe question is about whether management describes the company currently moving itself further up or down its own value chain, taking ownership of a step that someone else used to perform, and that th...YES The transcript shows management describing the 2021 acquisition of the Beaumont plasma collection center as the company's entry into U.S. plasma collection, with the explicit goal of becoming a "fully integrated specialty plasma product company." They state they are "successfully expanding" capacity at the first center (already acquired and operational) and plan to open the second in Houston in early 2024. This is presented as an active, ongoing move to internalize plasma collection that previously depended on external suppliers.